Print Advertisements for Alzheimer’s Disease Drugs
| Autor: | Jonathan Gooblar, Brian D. Carpenter |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Direct-to-consumer advertising
Consumer Health Information Drug Industry business.industry General Neuroscience Advertising Disease Article Psychiatry and Mental health Clinical Psychology Health Information Management Transformational leadership Alzheimer Disease Content analysis Physicians Humans Medicine Periodicals as Topic Geriatrics and Gerontology business Nootropic Agents Aged |
| Zdroj: | American Journal of Alzheimer's Disease & Other Dementiasr. 28:355-362 |
| ISSN: | 1938-2731 1533-3175 |
| DOI: | 10.1177/1533317513488912 |
| Popis: | Purpose: We examined print advertisements for Alzheimer’s disease drugs published in journals and magazines between January 2008 and February 2012, using an informational versus transformational theoretical framework to identify objective and persuasive features. Methods: In 29 unique advertisements, we used qualitative methods to code and interpret identifying information, charts, benefit and side effect language, and persuasive appeals embedded in graphics and narratives. Results: Most elements contained a mixture of informational and transformational features. Charts were used infrequently, but when they did appear the accompanying text often exaggerated the data. Benefit statements covered an array of symptoms, drug properties, and caregiver issues. Side effect statements often used positive persuasive appeals. Graphics and narrative features emphasized positive emotions and outcomes. Implications: We found subtle and sophisticated attempts both to educate and to persuade readers. It is important for consumers and prescribing physicians to read print advertisements critically so that they can make informed treatment choices. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|